Inpatient Obstetric Nurse (NCC) Practice Exam

Antihypertensive medication should typically be initiated when blood pressure readings indicate a significant risk of complications for both the patient and the fetus. A reading exceeding 160/110 mmHg represents severe hypertension, which is associated with increased risks of maternal and fetal morbidity, including the potential development of conditions like preeclampsia or placental abruption.

At this threshold, the need for prompt intervention becomes critical to manage the condition effectively and prevent adverse outcomes. Starting treatment at this level of hypertension helps in stabilizing the patient and safeguarding both maternal and fetal health.

Lower readings may indicate mild to moderate hypertension, but they generally do not warrant immediate pharmacologic intervention unless there are other complicating factors present. Monitoring and lifestyle modifications are often sufficient at those levels, unless the situation escalates. Thus, initiating antihypertensives at a threshold of 160/110 mmHg is aligned with current guidelines and practices aimed at optimizing maternal-fetal outcomes.